BR9305991A - Derivados de indol como inibidores da esteróide 5 alfa redutase - Google Patents

Derivados de indol como inibidores da esteróide 5 alfa redutase

Info

Publication number
BR9305991A
BR9305991A BR9305991A BR9305991A BR9305991A BR 9305991 A BR9305991 A BR 9305991A BR 9305991 A BR9305991 A BR 9305991A BR 9305991 A BR9305991 A BR 9305991A BR 9305991 A BR9305991 A BR 9305991A
Authority
BR
Brazil
Prior art keywords
pct
steroid
reductase inhibitors
indole derivatives
alpha reductase
Prior art date
Application number
BR9305991A
Other languages
English (en)
Inventor
Graham Nigel Maw
Julian Blagg
Colin William Greengrass
Paul William Finn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9305991A publication Critical patent/BR9305991A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9305991A 1992-02-28 1993-02-16 Derivados de indol como inibidores da esteróide 5 alfa redutase BR9305991A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929204365A GB9204365D0 (en) 1992-02-28 1992-02-28 Indoles
PCT/EP1993/000380 WO1993017014A1 (en) 1992-02-28 1993-02-16 Indole derivatives as steroid 5 alpha-reductase inhibitors

Publications (1)

Publication Number Publication Date
BR9305991A true BR9305991A (pt) 1997-10-21

Family

ID=10711259

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9305991A BR9305991A (pt) 1992-02-28 1993-02-16 Derivados de indol como inibidores da esteróide 5 alfa redutase

Country Status (24)

Country Link
US (1) US5767139A (pt)
EP (1) EP0628040B1 (pt)
JP (1) JP2540016B2 (pt)
KR (1) KR950700287A (pt)
CN (1) CN1079465A (pt)
AT (1) ATE164376T1 (pt)
AU (1) AU3497793A (pt)
BR (1) BR9305991A (pt)
CA (1) CA2117610C (pt)
CZ (1) CZ207794A3 (pt)
DE (1) DE69317651T2 (pt)
DK (1) DK0628040T3 (pt)
ES (1) ES2115053T3 (pt)
FI (2) FI943931A0 (pt)
GB (1) GB9204365D0 (pt)
HR (1) HRP930227A2 (pt)
HU (1) HUT71126A (pt)
IL (1) IL104816A0 (pt)
MX (1) MX9301112A (pt)
NO (1) NO943187L (pt)
RU (1) RU94042391A (pt)
SK (1) SK100894A3 (pt)
WO (1) WO1993017014A1 (pt)
ZA (1) ZA931383B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles
GB9403516D0 (en) * 1994-02-24 1994-04-13 Pfizer Ltd Indoles
GB9409583D0 (en) * 1994-05-13 1994-07-06 Pfizer Ltd Indoles
US6069156A (en) * 1995-04-10 2000-05-30 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives as cGMP-PDE inhibitors
WO2000007590A1 (en) * 1998-08-03 2000-02-17 Eli Lilly And Company INDOLE sPLA2 INHIBITORS
FR2796274B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2796279B1 (fr) 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
MXPA05004929A (es) * 2002-11-07 2005-08-18 Akzo Nobel Nv Indoles utiles en el tratamiento de enfermedades relacionadas a receptor de androgeno.
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557142A (en) * 1968-02-20 1971-01-19 Sterling Drug Inc 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
PH23498A (en) * 1984-08-06 1989-08-16 Sterling Drug Inc 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles

Also Published As

Publication number Publication date
RU94042391A (ru) 1996-08-10
CN1079465A (zh) 1993-12-15
GB9204365D0 (en) 1992-04-08
HUT71126A (en) 1995-11-28
ES2115053T3 (es) 1998-06-16
EP0628040A1 (en) 1994-12-14
NO943187L (no) 1994-09-13
FI20001771A (fi) 2000-08-09
FI943931A (fi) 1994-08-26
CA2117610C (en) 2000-07-18
AU3497793A (en) 1993-09-13
DK0628040T3 (da) 1998-04-27
HRP930227A2 (en) 1996-10-31
DE69317651T2 (de) 1998-07-09
EP0628040B1 (en) 1998-03-25
ATE164376T1 (de) 1998-04-15
MX9301112A (es) 1994-07-29
JP2540016B2 (ja) 1996-10-02
IL104816A0 (en) 1993-06-10
DE69317651D1 (en) 1998-04-30
US5767139A (en) 1998-06-16
FI943931A0 (fi) 1994-08-26
CA2117610A1 (en) 1993-09-02
KR950700287A (ko) 1995-01-16
HU9402466D0 (en) 1994-10-28
NO943187D0 (no) 1994-08-29
SK100894A3 (en) 1995-04-12
JPH07500347A (ja) 1995-01-12
ZA931383B (en) 1994-08-26
WO1993017014A1 (en) 1993-09-02
CZ207794A3 (en) 1995-01-18

Similar Documents

Publication Publication Date Title
DK0687251T3 (da) 1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
ATE331726T1 (de) Adenine-derivate
BR9305991A (pt) Derivados de indol como inibidores da esteróide 5 alfa redutase
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
AU3410693A (en) Carbamate derivatives and their use in medicine
FI955707A0 (fi) Indolijohdannaiset steroidi-5alfa-reduktaasin inhibiittoreina
MX9303607A (es) Derivados de azabicicloheptano sustituidos, su obtencion y uso.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal